Takeda Selects Five New Partnerships for Annual Global Social Responsibility ... 2

Takeda Selects Five New Partnerships for Annual Global Social Responsibility …

  • Takedin's mission of founding serves patients wherever they are, the engine of choice commitment to partnership with the global community for disease prevention, capacity building and access to health care in developing and developing countries use.
  • As part of the annual Global CSR program, around 20,000 employees worldwide have voted for the City Challenge for Cancer, Dedicated Disease Diseases (DNDi), the SeriousFun Pediatric Network, UNICEF and the UN Trust Fund for Partners in 2019.
  • With these programs, Takeda contributed a total of 10.5 billion yen to a total of 14 programs since its launch in 2016 through its unique Global Debt Program.

Takeda Pharmaceutical Company Limited (TAKEO: 4502 / NYSE: TAK) ("Takeda") today announced the addition of five partners to its Global Growth Program for 2019, which will contribute to long-term health of people through disease prevention and capacity building in countries in developing and transition countries contributes. About 20,000 employees around the globe have voted and selected five new, major programs from the City's Challenges for Cancer, Drugs for Neglected Diseases initiative (DNDI, the children's network SeriousFun, UNICEF and the UN Foundation. All five programs will be run by the above listed organizations in partnership with Takeda. This year, Takeda increased its commitment to 4.6 billion yen to speed up changes in addressing some of the world's biggest challenges.

Takeda's Global CSR program, a leading CSR activity, is part of a multi-year commitment in partnership with key global stakeholders. The program is based on the patient's focus and commitment to disease prevention and access to health care, which changes people's lives in developing and developing countries. Since their launch in 2016, partnerships in the Global CSR program have yielded tangible results and are a major contributor to the efforts for sustainability of the global sustainable development goals. high-quality diagnosis and treatment, including immunization, in developing countries, training health care workers, and strengthening healthcare systems around the world.

"We look forward to helping improve life and collaborating with these creative and influential organizations to accelerate progress towards sustainable development goals," said Haruhiko Hirate, Head of Corporate Communications and Public Relations Department. "We know that long-term commitments are important, and we currently have nine programs ranging from three to ten years, each program carefully selecting employees in the 80 countries we work for." Takeda contributes to the health of people in communities around the world. "

As a pharmaceutical company devoted to improving human life, Takeda's vision of innovation in healthcare and a brighter future for people around the world are driven by leading innovations in medicine. His vision is a world of affordable health care, where prevention exponentially triggers and removes billions of illnesses. Takeda seeks to reach SDG together with the global community.

In addition to the following 14 programs, Takeda also supports public-private partnerships to improve health, together with the Japanese government around the world, such as the Global Fund for Innovative Health Technology (GHIT) and the Coalition for Preparedness for Epidemic Innovation (CEPI), Gobal's Fund for the fight against AIDS, tuberculosis and malaria).

Overview of programs and partner organizations in the financial year 2019

partner

Program description

territory

period

Budget (Yen)

1

SeriousFun children's network

Change the lives of seriously ill children and their families

USA, Europe, Africa, Asia and the Caribbean

5 years

1 billion

2

DNDI

The Global Access Program for the Most Neglected Patients

16 countries in Africa, Asia and South America

5 years

1 billion

3

City Challenge for Cancer

City Health Health Laboratory

globally

5 years

1 billion

4

UN Foundation

Vaccination and General Health Care

Sub-Saharan Africa *

5 years

550 million

5

UNICEF

Investing in innovation and state-of-the-art technology

globally

5 years

1 billion

The next nine programs, selected by Takeda employees in 2016, 2017, and 2018, are well advanced.

Overview of programs and partner organizations in the financial year 2018

partner

Program description

territory

period

Budget (Yen)

1

Last Mile Health

A health worker for everyone, everywhere and anytime

globally

3 years

400 million

2

Seed Global Health

Training of 5,000 health professionals in sub-Saharan Africa

Sub-Saharan Africa *

5 years

500 million

3

UNICEF

Strengthening the Health System in Sub-Saharan Africa

Angola, Guinea and Togo

5 years

500 million

Program Sketches and Partner Organizations in FG 2017

partner

Program description

territory

period

Budget (Yen)

1

UNICEF

"The First 1000 Days": Health and Nutrition Program

Benin, Madagascar and Rwanda

5 years

1 billion

2

Plan International

Holistic refugee support program from South Sudan and Syria

Egypt, Jordan, Lebanon, South Sudan, Sudan, Uganda and Ethiopia

5 years

1 billion

3

JOICFP

Protection of pregnant women in Africa

Ghana, Tanzania, Kenya and Zambia

5 years

750 million

Overview of Programs and Partner Organizations in FG 2016

partner

Program description

territory

period

Budget (Yen)

1

UN Foundation

Global vaccine against poultry

About 40 countries in Africa, Asia and Latin America

10 years

1 billion

2

World Vision

Training of health workers in the community for the health of mothers and children

India, Bangladesh, Nepal and Afghanistan

5 years

500 million

3

Save the kids

Maternal and infant health among ethnic minorities

Myanmar, Vietnam and Laos

5 years

250 million

* Sustainable Development Goals: September 25, 2015 The United Nations have adopted 17 goals under the Sustainable Development Agenda 2030, including 169 sustainable development goals.

Description of partner organizations and programs

1. SeriousFun Pediatric Network: The Life of Children With Severe Diseases and Their Families

Overview: This program aims to develop and expand new and innovative programs for the global network of specialized medical camps and programs that provide a life-changing experience for children with serious diseases and their families; Carry out research and evaluation to monitor the impact of the camp on the lives of children and families and to further improve the programs to meet their needs; build medical capacity throughout the network.

– Regions: United States, Europe, Africa, Asia and the Caribbean

– Period: 5 years

– Budget: 1 billion yen

2. DNDi: A Global Access Program for Most Neglected Patients

– Overview: The aim of this program is to increase the access of neglected patients to high quality diagnosis and treatment in pathogenic countries, including those in peripheral areas, which prevents disease progression while saving lives. DNDIfocuses on five neglected tropical diseases (NTDs): Sleep Disease, Chagas disease, leishmaniasis, onchocerciasis and mycetoma, characterized by significant morbidity and / or mortality and because of the currently limited availability and availability of effective diagnosis and treatment, were priority:

– Regions: 16 countries in Africa, Asia and South America

– Period: 5 years

– Budget: 1 billion yen

3. City Challenge for Cancer: City Health Financing Lab

– Concept: The participatory and inclusive approach that causes cancer in the city brings together the private sector, civil society and government to improve the quality of care and treatment of cancer and strengthen health systems. Supporting 10 cities in developing, planning and implementing sustainable cancer solutions, the City's cancer challenge will reach 80 million people by 2023.

– Regions: Global

– Period: 5 years

– Budget: 1 billion yen

4. UN Foundation: Vaccination and General Health Care

– Brief Overview: The partnership between Takeda and Shot @ Life aims to strengthen health systems in sub-Saharan Africa through improved disease tracking and data recovery, enabling effective planning and response to immunization. Strengthening vaccination programs will reach more children, strengthen primary health care and bring these countries closer to general health care

– Regions: Sub-Saharan Africa

– Period: 5 years

– Budget: 550 million yen

5. UNICEF: investing in innovation and state-of-the-art technology

– Overview: This program will invest in the establishment of new healthcare facilities and unmanned aerial vehicles to develop, implement and expand innovative child-based solutions as well as epidemiological modeling based on artificial intelligence to predict the occurrence of infectious diseases in three countries. and prevent:

– Regions: Global

– Period: 5 years

– Budget: 1 billion yen

About the SeriousFun Network

The SeriousFun Pediatric Network is a global community of 30 camps and programs that help children with serious diseases and their families, always free of charge. The network is headed by specialized medical camps, providing over a million experiences for children and families from more than 50 countries. Each camp is an independent, non-profit organization that relies on private means to serve its children at no cost to their families. More information about SeriousFun can be found at www.seriousfunnetwork.org.

About DNDi

DND acts as a non-profit R & D organizationI develop new ways of treating neglected diseases such as leishmaniasis, filarial infections, African human illness, Chagas disease and mycotoma, as well as neglected patients, including pediatric HIV patients and people living with hepatitis C virus, and inability to access because of high costs. cure. DNDI has developed eight new treatments, including new combinations of drugs for visceral leishmaniasis, two fixed dose antimalarias and DNDIThe first one has successfully developed a new chemical, phenylazidone, which was approved in 2018 for the treatment of both stages of sleeping. www.dndi.org

About cancer city challenge

The City Cancer Challenge mission is to create a global community of cities and partners working together on the development, planning and implementation of life-saving cancer solutions. Our goal is to improve access to quality cancer care in countries around the world by changing the way local, regional and national stakeholders work in designing, planning and implementing local cancer solutions. The approach is based on the explanation that cities can improve their impact at national level by developing data-based solutions, with support from global, regional and local partner networks that reflect the understanding of a unique local context. https://citycancerchallenge.org/

About the UN Fund

In our interconnected world, our common future is based on our ability to work together in a common goal. The United Nations is designed to strengthen international ties for common interests and values. It is the only place where all nations and citizens can join forces to solve our greatest challenges and create a better world for everyone. The UN Foundation supports the ability of the United Nations to take on these challenges and exploit opportunities for the benefit of all mankind. As we move deeper into the 21st century, this task is more urgent than ever. We work by building communities and establishing UN support initiatives and its priority topics, including achieving the goals of sustainable development. https://shotatlife.org/

About UNICEF

UNICEF works in some of the most difficult places in the world to reach the most vulnerable children in the world. In more than 190 countries we work for every child, every place, to build a better world for everyone.

Follow UNICEF twitter and Facebook

About Takeda Pharmaceutical Company Limited

Takeda Pharmaceutical Company Limited (TOKYO: 4502 / NYSE: TAK) is a global leading biopharmaceutical research group headquartered in Japan. He sees his mission in assisting patients in achieving better health and a more positive future through obtaining highly innovative medicines from scientific research. Takeda's research and development efforts focus on four therapeutic areas: oncology, gastroenterology (GI), rare diseases and neuroscience. We also invest targeted parts of our research budget in plasma medication and vaccine therapy. We focus on the development of highly innovative medicines that help improve the quality of people's lives effectively. To do so, we open new treatment options and use our enhanced, synergistic research area and our common ability to create a robust, multimodal pipeline. Our employees are committed to improving the quality of life of patients and working with our healthcare partners in about 80 countries and regions.

Please visit https://www.takeda.com for more information

The original language on which the original text was published is an official and authorized version. Translations are secured for better understanding. Only the language version is published in the original legitimate. Compare translations with the original language version of the publication.

See the original version at businesswire.com: https://www.businesswire.com/news/home/20190628005552/en/

Press contact:

Takeda Pharmaceutical Company Limited

Kazumi Kobayashi

kazumi.kobayashi@takeda.com

+81 (0) 3 3278 2095